Gentian Diagnostics ASA (OSL: GENT)
Norway
· Delayed Price · Currency is NOK 50.00
-2.50 (-4.76%)
Aug 30, 2024, 4:27 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 771.12 million as of August 30, 2024. Its market cap has increased by 11.11% in one year.
Market Cap
771.12M
Enterprise Value
697.87M
Revenue
151.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.00
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 771.12M, an increase of 166.25%. That is a compound annual growth rate of 13.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.02B |
| Nordhealth AS | 2.93B |
| Nykode Therapeutics AS | 2.10B |
| Photocure ASA | 1.51B |
| Carasent ASA | 1.31B |
| ArcticZymes Technologies ASA | 969.33M |
| Hofseth BioCare ASA | 842.72M |
| Navamedic ASA | 507.29M |